Chronic hypothyroidism induces abnormal structure of high-density lipoproteins and impaired kinetics of apolipoprotein A-I in the rat

Metabolism: Clinical and Experimental

Volumn 51, Issue 4, 2002, Pages 443-450

  Huesca Gómez, Claudia ^a,b   Franco, Martha ^a,b   Luc, Gérald ^a,b   Montaño, Luis F ^a,b   Massó, Felipe ^a,b   Posadas Romero, Carlos ^a,b   Pérez Méndez, Oscar ^a,b  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; APOLIPOPROTEIN C; APOLIPOPROTEIN E; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IODINE 125; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; PROTEIN; THYROID HORMONE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; HYPOTHYROIDISM; ISOTOPE LABELING; LIPID COMPOSITION; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIPOPROTEIN SYNTHESIS; MALE; METABOLIC DISORDER; METABOLIC RATE; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN ISOLATION; PROTEIN STRUCTURE; RAT; REGULATORY MECHANISM; SPECIES; STATISTICAL SIGNIFICANCE; STRUCTURE ANALYSIS; THYROIDECTOMY;

EID: 0036114026     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.31323     Document Type: Article

References (60)

1. Molecular physiology of reverse cholesterol transport
2. High-density lipoprotein: A major risk factor for coronary atherosclerosis
3. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study
4. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein
5. A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells
6. Familial disorders of high-density lipoprotein metabolism
7. Role of thyroid hormones in apolipoprotein A-I gene expression in rat liver
8. Thyroid hormone influences conditional transcript elongation of the apolipoprotein A-I gene in rat liver
9. Identification of functional positive and negative thyroid hormone-responsive elements in the rat apolipoprotein AI promoter
10. Triiodothyronine increases rat apolipoprotein A-I synthesis and alters high-density lipoprotein composition in vivo
11. Beneficial effects of a novel thyromimetic on lipoprotein metabolism
12. Effects of L-triidothyronine and the thyromimetic L-94901 on serum lipoprotein levels and hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and apo A-I gene expression
13. Hypothyroidism reduces HDL binding to rat liver cells
14. Time-course of alterations of high-density lipoproteins (HDL) during thyroxine administration to hypothyroid women
15. Cholesterol metabolism in hypothyroidism and hyperthyroidism in man
16. Dyslipoproteinaemia in hypothyroidism of pituitary origin: Effects of L-thyroxine substitution on lipoprotein lipase, hepatic lipase, and on plasma lipoproteins
17. Serum lipids and apolipoproteins A-I, A-II and B in primary hypothyroidism before and during treatment
18. Serum high-density lipoprotein cholesterol concentrations in hypo- and hyperthyroidism
19. Clinical review 115: Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: A quantitative review of the literature
20. The activity of cholesteryl ester transfer protein is decreased in hypothyroidism: A possible contribution to alterations in high-density lipoproteins
21. Effect of thyroid dysfunction on high-density lipoprotein subfraction metabolism: Roles of hepatic lipase and cholesteryl ester transfer protein
22. Plasma cholesteryl ester transfer protein and high-density lipoproteins: New insights from molecular genetic studies
23. Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia
24. Delayed catabolism of high-density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency
25. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II
26. Apolipoprotein A-I charge and conformation regulate the clearance of reconstituted high density lipoprotein in vivo
27. Production rate determines plasma concentration of large high-density lipoprotein in non-human primates
28. Small HDL particles containing two apoA-I molecules are precursors in vivo to medium and large HDL particles containing three and four apoA-I molecules in non-human primates
29. Metabolism of apolipoproteins AI and AII in subjects carrying similar apoAI mutations, apoAI Milano and apoAI Paris
30. Rat plasma lipoproteins: Re-evaluation of a lipoprotein system in an animal devoid of cholesteryl ester transfer activity
31. Adenosine regulates renal nitric oxide production in hypothyroid rats
32. Protein measurement with the Folin phenol reagent
33. Immunological properties of apoB-containing lipoprotein particles in human atherosclerotic arteries
34. Identifying the predominant peak diameter of high-density and low-density lipoproteins by electrophoresis
35. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
36. The metabolism of very low density lipoproteins. Preliminary in vitro and in vivo observations
37. Apolipoprotein AI levels are increased in part as a consequence of reduced catabolism in nephrotic rats
38. Impared atrial natriuretic factor systemic clearance contributes to its higher levels in uremia
39. Participation of adenosine in the renal hemodynamic abnormalities of hypothyroidism
40. Effects of hypothyroidism and high-fat feeding on mRNA concentrations for the low-density-lipoprotein receptor and on acyl-CoA:cholesterol acyltransferase activities in rat liver
41. Tri-iodothyronine prevents the amiodarone-induced decrease in the expression of the liver low-density lipoprotein receptor gene
42. The magnitude of the hypercholesterolemia of hypothyroidism is associated with variation in the low-density lipoprotein receptor gene
43. Rate of cholesteryl ester transfer between high and low density lipoproteins in human serum and a case with decreased transfer rate in association with hyperalphalipoproteinemia
44. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins
45. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice
46. Weight loss and plasma lipids
47. The efficacy of accumulated short bouts versus single daily bouts of brisk walking in improving aerobic fitness and blood lipid profiles
48. Effects of experimental hypothyroidism on the distribution of lipids and lipoproteins in the plasma of rats
49. Secretion of nascent lipoproteins by isolated hepatocytes from hypothyroid and hypothyroid, hypercholesterolemic rats
50. The modulation of apolipoprotein E gene expression by 3,3′-5-triiodothyronine in HepG2 cells occurs at transcriptional and post-transcriptional levels
51. Role of thyroid hormone in the expression of apolipoprotein A-IV and C-III genes in rat liver
52. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels
53. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes
54. Fish-eye disease: Structural and in vivo metabolic abnormalities of high-density lipoproteins
55. Kinetic and metabolic studies of apo A-I and apo A-II in a hypoalphalipoproteinemic patient
56. Clearance of postprandial and lipolytically modified human HDL in rabbits and rats
57. Metabolism of larger high density lipoproteins accumulating in some families of baboons fed a high cholesterol and high saturated fat diet
58. Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the apoA-IV-2 isoprotein